Moderate weight loss improves heart function in obese

Moderate weight loss in obese people improves heart function – Obese patients who lost a moderate amount of weight by eating less and exercising more improved their cardiovascular health, revealed by researchers.

Successful weight control strategies for adolescent obesity

Investigators identify successful weight control strategies for adolescents — New study published in the Journal of the American Dietetic Association – Adolescent obesity is a major public health problem that impacts one out of every three children, resulting in 4-5 million overweight youth in the United States.

Low fat diet improves mood in dieters

Mood improves on low-fat, but not low-carb, diet plan – A low calorie, low fat diet appears more beneficial to dieters’ mood than a low carbohydrate plan with the same number of calories, revealed by researchers.

Patients with acute lower back pain can be diagnosed by PCP

PCPs are front line defense in diagnosing serious illness in patients with acute lower back pain — ‘Red flag’ clinical features aid PCPs in screening patients for serious diseases. – Primary care physicians are front line defense in diagnosing serious illness in patients with acute lower back pain, revealed by researchers at The George Institute for International Health in Australia.

New insights into anorexia nervosa

Review provides new insights into the causes of anorexia – individuals with anorexia have an imbalance between circuits in the brain that regulate reward and emotion. – New imaging technology provides insight into abnormalities in the brain circuitry of patients with anorexia nervosa (commonly known as anorexia) that may contribute to the puzzling symptoms found in people with the eating disorder.

Orexigen’s Contrave trials successful for obesity treatment

Contrave Helps Obese Patients Initiate and Sustain Meaningful Weight Loss, Improves Multiple Cardiometabolic Risk Factors and Reduces Food Cravings. – Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced that all three remaining Phase 3 trials evaluating Contrave(R) (bupropion SR/naltrexone SR), its investigational drug for the treatment of obesity, met their co-primary endpoints.

Young You recalls weight loss pills

Young You Corporation Issues a Voluntary Nationwide Recall of Weight Loss Pills Found to Contain an Undeclared Drug Ingredient – Young You Corporation has been informed by the Food and Drug Administration (FDA) that four weight loss dietary supplements sold and marketed by the firm contain an undeclared drug ingredient.

Obesity leads to rapid cartilage loss

Obesity contributes to rapid cartilage loss – Obesity is strongly associated with an increased risk of rapid cartilage loss, revealed by researchers at Boston University. The study published in the August issue of Radiology.

Bariatric surgery relatively safe for weight loss

Large-scale analysis finds bariatric surgery relatively safe – Advances in bariatric surgery (weight loss surgery) have made this procedure as safe as any routine surgical procedure, as per researchers at Duke University Medical Center.

6 months to lose weight gained in pregnancy

Women are under too much pressure to lose weight quickly after giving birth, according to German institute – Gaining weight in pregnancy is not only normal, it is necessary. The mother’s body has to nourish the growing baby. Her body needs to take on more fluid to support the extra circulation the placenta and baby need.

Smoking promotes insulin resistance and then heart disease

Researcher explores why smoking increases the risk of heart disease and strokes – Researchers at Charles Drew University of Medicine and Science in Los Angeles and Western University of Health Sciences in Pomona have discovered a reason why smoking increases the risk of heart disease and strokes.

Diabetes drug exenatide helped nondiabetic obese individuals

Diabetes drug exenatide helped nondiabetic obese individuals — Exenatide promotes weight loss when added to diet and exercise. – In combination with diet and exercise, the diabetes drug exenatide helped nondiabetic, obese individuals lose over three times more weight than those receiving a placebo, or dummy treatment, for 6 months.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia